Johnson & Johnson Sees Heavy Put Activity as $2.68M Bet Targets Near-Term Downside

By TrendSpider Editor

A dominant bearish options contract is drawing attention in Johnson & Johnson (JNJ) today, with a single put position carrying a premium of $2,683,980 standing out against a comparatively minor call. JNJ shares are currently trading at $281.235, down 0.54% on the session, and sitting near the upper

Johnson & Johnson Sees Heavy Put Activity as $2.68M Bet Targets Near-Term Downside

A dominant bearish options contract is drawing attention in Johnson & Johnson (JNJ) today, with a single put position carrying a premium of $2,683,980 standing out against a comparatively minor call. JNJ shares are currently trading at $281.235, down 0.54% on the session, and sitting near the upper end of their 52-week range of $195.90 to $290.2495. The lopsided options flow, totaling $2,719,705 in combined premium across just two unusual contracts, suggests at least some institutional participants are positioning defensively heading into the final weeks of November 2026.

Key Drivers of the JNJ Stock Move

The forward setup for JNJ warrants close attention over the next two weeks, given that both flagged options contracts expire before the end of November 2026. The in-the-money put expiring November 27 gives bears a tight window to profit if the stock pulls back toward or below $280. With JNJ trading just $9 below its 52-week high of $290.2495, any broader market softness or company-specific news could quickly accelerate a move in either direction. Investors should monitor whether additional unusual options flow develops in the days ahead, particularly ahead of any scheduled corporate events or macroeconomic catalysts that could influence large-cap healthcare names.

JNJ Unusual Options Activity

Two unusual contracts were flagged in JNJ today, with the put side accounting for the overwhelming majority of total premium activity:

The total premium across both contracts is $2,719,705, with the put representing approximately 98.7% of that figure. The in-the-money status of the put and its proximity to the current share price of $281.235 makes it a high-conviction near-term directional trade worth watching closely through the November 27 expiration.

JNJ Seasonality

Mid-to-late November has historically represented a transitional period for large-cap healthcare stocks, as institutional investors reassess portfolio positioning ahead of year-end. The concentration of these contracts in the November 20 and November 27 expiration windows suggests traders are focused on capturing any near-term volatility rather than making longer-dated macro bets.

JNJ Relative Performance

JNJ's current price of $281.235 places it roughly 43% above its 52-week low of $195.90 and within approximately 3.2% of its 52-week high of $290.2495, indicating that the stock has been among the stronger performers in the large-cap healthcare space over the trailing year. Today's modest decline of 0.54% is relatively contained, though the heavy put premium flagged in today's session suggests at least some market participants anticipate a near-term retracement from these elevated levels.

More on JNJ

Latest Market News